Ligand validation:6W79

X77: N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide

X77 is a Ligand Of Interest in 6W79 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6W79_X77_A_402	50%	12%	0.142	0.892	2.17	1.9	5	12	0	0	100%	0.711
8P58_X77_A_406	93%	46%	0.077	0.971	0.98	1.11	2	2	0	0	100%	1
7PHZ_X77_A_401	91%	39%	0.079	0.965	1.12	1.25	3	3	0	0	100%	1
8P5A_X77_A_410	90%	48%	0.081	0.963	0.95	1.04	3	2	0	0	100%	1
6W63_X77_A_401	88%	16%	0.081	0.955	2.1	1.57	6	6	1	0	100%	1
8P56_X77_A_406	35%	45%	0.212	0.901	1.01	1.1	2	4	0	0	100%	1
6W81_X77_B_401	46%	12%	0.139	0.872	2.2	1.91	7	10	0	0	100%	0.826

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.